Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Precision Medicine Technique Devised for Brain Tumors

Brain tumor graphic

A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors. . . . → Read More: Precision Medicine Technique Devised for Brain Tumors

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

Infographic – U.S. Smoking Rate Hits New Low

Chart: smoking in the U.S.

These data show fewer than 1 in 6 Americans, or 16 percent, smoked a cigarette in the past week. . . . → Read More: Infographic – U.S. Smoking Rate Hits New Low

Merck, Biopharma Partner on Cell-Free Immune System Therapies

Cancer magnified

Drug maker Merck is acquiring the rights to therapies for cancer and autoimmune disorders based on a technology for developing synthetic proteins from a process that bypasses live cells. . . . → Read More: Merck, Biopharma Partner on Cell-Free Immune System Therapies

RNA Nanoparticles Designed for Brain Cancer Therapy

Brain cell networks

Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer. . . . → Read More: RNA Nanoparticles Designed for Brain Cancer Therapy

Nanoparticles Shown to Boost Anti-Cancer Immune Cells

Cytokines and T-cells

A bioengineering lab developed a technique to attach larger quantities of cancer-fighting proteins to immune system cells that in lab mice reduced or eliminated tumors while avoiding harmful side effects. . . . → Read More: Nanoparticles Shown to Boost Anti-Cancer Immune Cells

Engineered Polio Virus Tested as Brain Cancer Treatment

Brain tumor graphic

Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment

Cancer T-Cell Start-Up Gains $150 Million in IPO

NASDAQ share price display

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

Engineered T-Cells Tested for Childhood Brain Cancer

Human T-cell

A clinical trial is getting underway testing modified T-cells from the immune system in children and young adults with brain tumors that do not respond to other treatments. . . . → Read More: Engineered T-Cells Tested for Childhood Brain Cancer

Hospital Network Formed for Childhood Cancer Immunotherapies

T-cells illustration

A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies